[go: up one dir, main page]

AR070458A1 - Derivados de oxazolidina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de una infeccion bacteriana. - Google Patents

Derivados de oxazolidina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de una infeccion bacteriana.

Info

Publication number
AR070458A1
AR070458A1 ARP090100598A ARP090100598A AR070458A1 AR 070458 A1 AR070458 A1 AR 070458A1 AR P090100598 A ARP090100598 A AR P090100598A AR P090100598 A ARP090100598 A AR P090100598A AR 070458 A1 AR070458 A1 AR 070458A1
Authority
AR
Argentina
Prior art keywords
preparation
treatment
bacterial infection
group
oxazolidine
Prior art date
Application number
ARP090100598A
Other languages
English (en)
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of AR070458A1 publication Critical patent/AR070458A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Uso de estos compuestos en la elaboracion de un medicamento para la prevencion o tratamiento de una infeccion bacteriana y en composiciones farmacéuticas. Reivindicacion 1: Un compuesto de la formula (1) en donde ô-------ô es un enlace, o está ausente; R1 representa a alcoxi C1-4 o halogeno; R1b representa a H o alquilo C1-3; U y V representan cada uno independientemente a CH o N; W representa a CH o N, o, en caso de que ô----ô esté ausente, W representa a CH2 o NH; con la condicion de que por lo menos uno de U, V y W represente a CH o CH2; A representa a -CH2-CH(R2)-B-NH-* o CH(R3)-CH2-N(R4)-[CH2]m-*; donde los asteriscos indican el enlace que está unido a través del grupo CH2- a la porcion oxazolidinona; B representa a CH2 o CO; y R2 representa a hidrogeno, OH o NH2; R3 y R4 representan ambos a hidrogeno, o R3 y R4 juntos forman un puente metileno; m representa al entero 0, 1 o 2; y G representa a fenilo que es monosustituido en la posicion 3 o 4, o disustituido en las posiciones 3 y 4, en donde cada substituyente es seleccionado independientemente del grupo constituido por alquilo C1-4, alcoxi C1-3 y halogeno; o G representa a un grupo seleccionado del grupo constituido por los grupos G1, G2, G3, G4, G5 y G6 donde M representa a CH o N; Q y Q' representan independientemente a S u O; ò Z1 representa a N, Z2 representa a CH, y Z3 representa a CH; o ò Z1 representa a CH, Z2 representa a N, y Z3 representa a CH o N; o ò Z1 representa a CH, Z2 representa a CR5, y Z3 representa a CH; o ò Z1 representa a CH, Z2 representa a CH, y Z3 representa a N; y R5 representa a hidrogeno o fluor; o una sal de tal compuesto.
ARP090100598A 2008-02-22 2009-02-20 Derivados de oxazolidina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de una infeccion bacteriana. AR070458A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2008050651 2008-02-22
IB2008054095 2008-10-07

Publications (1)

Publication Number Publication Date
AR070458A1 true AR070458A1 (es) 2010-04-07

Family

ID=40578768

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090100598A AR070458A1 (es) 2008-02-22 2009-02-20 Derivados de oxazolidina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de una infeccion bacteriana.

Country Status (14)

Country Link
US (1) US8349826B2 (es)
EP (1) EP2254887B9 (es)
JP (1) JP5404652B2 (es)
KR (1) KR101592046B1 (es)
CN (1) CN102015698B (es)
AR (1) AR070458A1 (es)
BR (1) BRPI0908208A2 (es)
CA (1) CA2713187C (es)
ES (1) ES2398939T3 (es)
MX (1) MX2010008921A (es)
PL (1) PL2254887T3 (es)
RU (1) RU2501799C2 (es)
TW (1) TWI429643B (es)
WO (1) WO2009104159A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2411930T3 (es) 2008-02-20 2013-07-09 Actelion Pharmaceuticals Ltd. Compuestos antibióticos azatricíclicos
CN104151315B (zh) 2008-10-07 2017-01-11 埃科特莱茵药品有限公司 三环噁唑烷酮抗生素化合物
JP2012505201A (ja) * 2008-10-10 2012-03-01 アクテリオン ファーマシューティカルズ リミテッド 2−ベンゾチオフェニル−及び2−ナフチル−オキサゾリジノン、並びにそれらのアザアイソスター(azaisostere)類似体
US8507478B2 (en) 2008-10-10 2013-08-13 Actelion Pharmaceuticals Ltd. Oxazolidinyl antibiotics
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
EP2674430A4 (en) 2011-02-07 2014-07-02 Daiichi Sankyo Co Ltd AMINO-GROUP-PYRROLIDINONE DERIVATIVES
US8916573B2 (en) 2011-08-11 2014-12-23 Actelion Pharmaceuticals Ltd. Quinazoline-2,4-dione derivatives
US9079922B2 (en) * 2011-11-08 2015-07-14 Actelion Pharmaceuticals Ltd 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives
WO2013080156A1 (en) 2011-11-30 2013-06-06 Actelion Pharmaceuticals Ltd 3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics
WO2014024056A1 (en) 2012-08-06 2014-02-13 Daiichi Sankyo Company, Limited Pyrrolidine derivatives with antibacterial properties
EP2943492A1 (en) 2013-01-09 2015-11-18 Actelion Pharmaceuticals Ltd. Antibacterial oxadiazolone derivatives
PL2986607T3 (pl) 2013-04-16 2017-11-30 Idorsia Pharmaceuticals Ltd Przeciwbakteryjne pochodne biaromatyczne
CA2910177A1 (en) 2013-05-08 2014-11-13 Actelion Pharmaceuticals Ltd Antibacterial phthalide derivatives
AR102256A1 (es) 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi
EP3413976A1 (en) * 2016-02-08 2018-12-19 Redx Pharma PLC Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds
GB201602235D0 (en) * 2016-02-08 2016-03-23 Redx Pharma Plc Antibacterial compounds
WO2017137743A1 (en) * 2016-02-08 2017-08-17 Redx Pharma Plc Antibacterial compounds
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物
ES2942761T3 (es) * 2017-06-08 2023-06-06 Bugworks Res Inc Compuestos heterocíclicos útiles como agentes antibacterianos y método para la producción de los mismos
EP3717490B1 (en) * 2017-11-29 2023-05-24 Bugworks Research, Inc. Anti-bacterial heterocyclic compounds and their synthesis
SMT202300130T1 (it) * 2018-03-28 2023-05-12 Bugworks Research Inc Composti antibiotici ossazolidinone e processo di preparazione

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2168696B (en) 1984-12-21 1989-01-11 Boehringer Biochemia Srl Fluoro coumarins as antilymphoedema agents
CA2012681A1 (en) 1989-03-31 1990-09-30 Masayasu Okuhira Quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same
DE19514313A1 (de) * 1994-08-03 1996-02-08 Bayer Ag Benzoxazolyl- und Benzothiazolyloxazolidinone
CN1163892A (zh) * 1996-01-16 1997-11-05 拜尔公司 2-氧代-和2-硫代-1,2-二氢喹啉基-噁唑烷酮类化合物
DE19601265A1 (de) * 1996-01-16 1997-07-17 Bayer Ag 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone
DE19604223A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
WO2001030782A2 (en) 1999-10-29 2001-05-03 Syngenta Participations Ag Novel herbicides
GB0031086D0 (en) 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
FR2852954B1 (fr) * 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
CN1898238A (zh) * 2003-12-18 2007-01-17 莫弗凯姆联合化学股份公司 噁唑烷酮-喹诺酮杂化物抗生素
WO2006024741A2 (fr) * 2004-07-30 2006-03-09 Palumed S.A. Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
DE602006013878D1 (de) 2005-12-22 2010-06-02 Glaxo Group Ltd Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
EP1987025B1 (en) * 2006-02-14 2009-09-16 Pfizer Products Inc. Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents
KR101409261B1 (ko) 2006-05-26 2014-06-18 다이쇼 세이야꾸 가부시끼가이샤 신규의 복소환 화합물 또는 그 염 및 그 중간체
EP2404913A3 (en) 2006-06-16 2012-06-06 Pharma Mar S.A. Process and intermediates for the preparation of antitumoral dihydropyran-2-one compounds
DE602007012133D1 (de) 2006-12-01 2011-03-03 Andrew Burritt Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
CL2008001002A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001003A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.

Also Published As

Publication number Publication date
JP2011512401A (ja) 2011-04-21
US8349826B2 (en) 2013-01-08
WO2009104159A1 (en) 2009-08-27
TWI429643B (zh) 2014-03-11
US20100331308A1 (en) 2010-12-30
CA2713187A1 (en) 2009-08-27
TW200940534A (en) 2009-10-01
RU2010138840A (ru) 2012-03-27
AU2009215247A1 (en) 2009-08-27
JP5404652B2 (ja) 2014-02-05
RU2501799C2 (ru) 2013-12-20
CN102015698A (zh) 2011-04-13
ES2398939T3 (es) 2013-03-22
EP2254887B9 (en) 2013-05-29
EP2254887B1 (en) 2012-12-19
EP2254887A1 (en) 2010-12-01
MX2010008921A (es) 2010-09-07
ES2398939T9 (es) 2013-07-24
CN102015698B (zh) 2014-08-27
KR20100124282A (ko) 2010-11-26
CA2713187C (en) 2016-06-07
KR101592046B1 (ko) 2016-02-05
PL2254887T3 (pl) 2013-05-31
BRPI0908208A2 (pt) 2015-08-25

Similar Documents

Publication Publication Date Title
AR070458A1 (es) Derivados de oxazolidina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de una infeccion bacteriana.
GEAP202416435A (en) Anti-viral compounds
GB0612423D0 (en) Therapeutic agents
PE20090042A1 (es) Analogos de ciclopamina
BRPI0410714B8 (pt) derivados de quinazolina macrocíclicos, seu processo de preparação, composição farmacêutica que os compreende e uso
AR081626A1 (es) Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
EP1389463A4 (en) MEDICAMENT FOR INHIBITING A DRUG REMOVAL PUMP
AR066012A1 (es) Derivados oxazolidinona, medicamento, composicion farmaceutica y uso en infecciones bacterianas
AR034448A1 (es) Uso de derivados de nucleosidos, dichos derivados de nucleosidos para dicho uso, composiciones farmaceuticas que los comprenden y uso de dichas composiciones
EA200971026A1 (ru) Новые макроциклические ингибиторы репликации вируса гепатита с
AR081331A1 (es) Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
BRPI0921701B8 (pt) Cefarosporina tendo um grupo catecol, seu uso e composição farmacêutica que a compreende
TNSN07471A1 (en) Novel 2,4 - dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
AR072488A1 (es) Derivados heterociclicos de 1,2,4-triazol, agonistas de receptores beta 2 adrenergicos y antagonistas muscarinicos colinergicos, composiciones farmaceuticas que los contienen y usos de los mismos en el tratamiento de afecciones respiratorias, inflamatorias y alergicas.
EA200971041A1 (ru) Новые пептидные ингибиторы репликации вируса гепатита с
AR065499A1 (es) Inhibidores de serino proteasas.composiciones farmaceuticas
AR063804A1 (es) Compuestos de azoniabiciclo[2.2.2]octano
AR015312A1 (es) Compuestos inhibidores no peptidilicos de la union a las celulas dependientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunesy respiratorias, composicion farmaceutica y uso de los compuestos en la preparacion de medicamentos
AR074604A1 (es) Derivados de 5-amino-2-(1-hidroxi-etil)-tetrahidropirano.
TW200724136A (en) Pharmaceutical compositions comprising PPAR modulator
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
DE602007001463D1 (de) Pyrimidin-, chinazolin-, pteridin- und triazinderivate
AR069800A1 (es) Derivados 5- aminociclilmetil - oxazolidin-2- ona
TW200616979A (en) Non-nucleoside reverse transcriptase inhibitors
DK2040703T3 (da) Derivater af 2-benzoylimidazopyridiner, fremstilling deraf og terapeutisk anvendelse deraf

Legal Events

Date Code Title Description
FB Suspension of granting procedure